MedTrace Logo

Jarlsberg Cheese Compared to Camembert Cheese

NCT04189796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-07-05

No results posted yet for this study

Summary

The study objective consists of the following three aims:

1. To compare the effect of daily intake of Jarlsberg cheese and Camembert cheese in change of the Osteocalcin level in healthy women after 6 weeks.
2. To estimate the long-term increase of the osteocalcin level, change in the lipid pattern and the vital signs caused by optimized daily intake of Jarlsberg cheese.
3. To verify the estimated maintaining dose of Jarlsberg cheese related to stabilized osteocalcin Level.

The study population consists of Healthy Voluntary (HV) women between 20 years and pre-menopausal age. The trial will be performed as a randomized Norwegian multicenter study with a semi-cross over design in which the participants randomized to Camembert cheese will be switched to Jarlsberg cheese after 6 weeks.

Conditions

  • Healthy Women
  • Osteocalcin

Interventions

DIETARY_SUPPLEMENT

Cheese

Daily oral intake of cheese

Sponsors & Collaborators

  • Norwegian University of Life Sciences

    collaborator OTHER

  • Tine

    collaborator INDUSTRY

  • Prof Stig Larsen

    lead OTHER

Principal Investigators

  • Helge E Lundberg, MD · Skjetten Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-16
Primary Completion
2020-09-18
Completion
2020-11-09

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04189796 on ClinicalTrials.gov